Mihai Netea

Last updated
Mihai Netea
MihaiNetea2016.jpg
Mihai Netea in 2016
Born1968

Mihai G. Netea (born 1968, Cluj, Romania) is a Romanian Dutch physician and professor at Radboud University Nijmegen, specialized in infectious disease, immunology, and global health.

Contents

Netea studied medicine at the Medico-Pharmaceutical Institute in Cluj-Napoca. [1] He received a doctoral degree in 1998 at Radboud University, with a dissertation on the role of cytokines in sepsis, [2] written under the direction of Jos van der Meer. [1]

He joined the University of Colorado as a postdoctoral researcher and then returned to conclude his clinical training as an infectious diseases specialist. [3] Since 2008 he heads the division of Experimental Medicine, Department of Internal Medicine, Nijmegen University Nijmegen Medical Center. [2]

Netea's field of study includes the innate immune system and its capacity to "memorize" infections, [3] as well as its recognition of Fungi pathogens. He examined system's response to Candida albicans , a sepsis trigger. Additionally, he tried to search for genetic diseases that can make individuals more vulnerable to this type of infections. [2]

Netea co-published more than 900 scientific papers [4] in journals such as New England Journal of Medicine, Nature, Science, and PNAS. [2]

For his academic work, Netea received several grants: a Vidi grant in 2005, a Vici grant in 2010, and European Research Council Consolidator Grant in 2012. [2] In 2016, he was awarded the Spinoza Prize. [5] [6] He is a member of Academia Europaea since 2015 and of the Royal Netherlands Academy of Arts and Sciences since 2016. [5] [7] [8]

Netea is known for his breakthrough in the area of Trained immunity Netea, Mihai G.; Joosten, Leo A. B.; Latz, Eicke; Mills, Kingston H. G.; Natoli, Gioacchino; Stunnenberg, Hendrik G.; o'Neill, Luke A. J.; Xavier, Ramnik J. (2016). "Trained immunity: A program of innate immune memory in health and disease". Science. 352 (6284). Science Mag: aaf1098. doi:10.1126/science.aaf1098. PMC   5087274 . PMID   27102489.. Netea's research attempts to translate information obtained through the assessment of human genetic variation in patients into novel diagnostic and therapeutic approaches.

Areas of research

Associated institutions

Positions held

Prizes and awards

Publications

Peer-reviewed (selection)

Science-fiction

Research grants

Patents

Related Research Articles

<span class="mw-page-title-main">Immune system</span> Biological system protecting an organism against disease

The immune system is a network of biological systems that protects an organism from diseases. It detects and responds to a wide variety of pathogens, from viruses to parasitic worms, as well as cancer cells and objects such as wood splinters, distinguishing them from the organism's own healthy tissue. Many species have two major subsystems of the immune system. The innate immune system provides a preconfigured response to broad groups of situations and stimuli. The adaptive immune system provides a tailored response to each stimulus by learning to recognize molecules it has previously encountered. Both use molecules and cells to perform their functions.

<span class="mw-page-title-main">Autoimmunity</span> Immune response against an organisms own healthy cells

In immunology, autoimmunity is the system of immune responses of an organism against its own healthy cells, tissues and other normal body constituents. Any disease resulting from this type of immune response is termed an "autoimmune disease". Prominent examples include celiac disease, diabetes mellitus type 1, Henoch–Schönlein purpura, systemic lupus erythematosus, Sjögren syndrome, eosinophilic granulomatosis with polyangiitis, Hashimoto's thyroiditis, Graves' disease, idiopathic thrombocytopenic purpura, Addison's disease, rheumatoid arthritis, ankylosing spondylitis, polymyositis, dermatomyositis, and multiple sclerosis. Autoimmune diseases are very often treated with steroids.

<span class="mw-page-title-main">Interleukin 10</span> Anti-inflammatory cytokine

Interleukin 10 (IL-10), also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine. In humans, interleukin 10 is encoded by the IL10 gene. IL-10 signals through a receptor complex consisting of two IL-10 receptor-1 and two IL-10 receptor-2 proteins. Consequently, the functional receptor consists of four IL-10 receptor molecules. IL-10 binding induces STAT3 signalling via the phosphorylation of the cytoplasmic tails of IL-10 receptor 1 + IL-10 receptor 2 by JAK1 and Tyk2 respectively.

<span class="mw-page-title-main">Interleukin 12</span> Interleukin

Interleukin 12 (IL-12) is an interleukin that is naturally produced by dendritic cells, macrophages, neutrophils, helper T cells and human B-lymphoblastoid cells (NC-37) in response to antigenic stimulation. IL-12 belongs to the family of interleukin-12. IL-12 family is unique in comprising the only heterodimeric cytokines, which includes IL-12, IL-23, IL-27 and IL-35. Despite sharing many structural features and molecular partners, they mediate surprisingly diverse functional effects.

<span class="mw-page-title-main">Granulopoiesis</span> Part of haematopoiesis, that leads to the production of granulocytes

Granulopoiesis is a part of haematopoiesis, that leads to the production of granulocytes. A granulocyte, also referred to as a polymorphonuclear leukocyte (PMN), is a type of white blood cell that has multi lobed nuclei, usually containing three lobes, and has a significant amount of cytoplasmic granules within the cell. Granulopoiesis takes place in the bone marrow. It leads to the production of three types of mature granulocytes: neutrophils, eosinophils and basophils.

<span class="mw-page-title-main">Interleukin 22</span> Protein, encoded in humans by IL22 gene

Interleukin-22 (IL-22) is protein that in humans is encoded by the IL22 gene.

<span class="mw-page-title-main">Toll-like receptor 2</span> Cell surface receptor found in humans

Toll-like receptor 2 also known as TLR2 is a protein that in humans is encoded by the TLR2 gene. TLR2 has also been designated as CD282. TLR2 is one of the toll-like receptors and plays a role in the immune system. TLR2 is a membrane protein, a receptor, which is expressed on the surface of certain cells and recognizes foreign substances and passes on appropriate signals to the cells of the immune system.

<span class="mw-page-title-main">CXCL9</span> Mammalian protein found in Homo sapiens

Chemokine ligand 9 (CXCL9) is a small cytokine belonging to the CXC chemokine family that is also known as monokine induced by gamma interferon (MIG). The CXCL9 is one of the chemokine which plays role to induce chemotaxis, promote differentiation and multiplication of leukocytes, and cause tissue extravasation.

<span class="mw-page-title-main">Toll-like receptor 4</span> Cell surface receptor found in humans

Toll-like receptor 4 (TLR4), also designated as CD284, is a key activator of the innate immune response and plays a central role in the fight against bacterial infections. TLR4 is a transmembrane protein of approximately 95 kDa that is encoded by the TLR4 gene.

<span class="mw-page-title-main">TREM1</span> Protein-coding gene in the species Homo sapiens

Triggering receptor expressed on myeloid cells 1 (TREM1) is an immunoglobulin (Ig) superfamily transmembrane protein that, in humans, is encoded by the TREM1 gene. TREM1 is constitutively expressed on the surface of peripheral blood monocytes and neutrophils, and upregulated by toll-like receptor (TLR) ligands; activation of TREM1 amplifies immune responses.

<span class="mw-page-title-main">Chronic mucocutaneous candidiasis</span> Medical condition

Chronic mucocutaneous candidiasis is an immune disorder of T cells. It is characterized by chronic infections with Candida that are limited to mucosal surfaces, skin, and nails. It can also be associated with other types of infections, such as human papilloma virus. An association with chromosome 2 has been identified.

<span class="mw-page-title-main">Jos van der Meer</span> Dutch scientist

Jos W.M. van der Meer is emeritus professor and former chairman at the department of internal medicine of the Radboud University Nijmegen Medical Centre in Nijmegen, Netherlands. He is a member of the Royal Netherlands Academy of Arts and Sciences, of which he was vice president and chairman of the division of natural sciences (2006-2012). He is a member of Academia Europaea. Between 2014 and 2016 he was president of European Academies Science Advisory Council (EASAC). He performs research on cytokines and host defence, chronic fatigue syndrome and hyper-immunoglobulinemia D syndrome (HIDS). He is also active in graphic art and makes cartoons, for example for the Dutch science journal Mediator.

<span class="mw-page-title-main">Interleukin 23</span> Heterodimeric cytokine acting as mediator of inflammation

Interleukin 23 (IL-23) is a heterodimeric cytokine composed of an IL-12B (IL-12p40) subunit and an IL-23A (IL-23p19) subunit. IL-23 is part of the IL-12 family of cytokines. The functional receptor for IL-23 consists of a heterodimer between IL-12Rβ1 and IL-23R.

Jean-Raymond Boulle, COR is a Monaco-based Mauritian businessman, the founder of four publicly traded companies with deposits of nickel, cobalt, copper, zinc, titanium and diamonds.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.

Immunological memory is the ability of the immune system to quickly and specifically recognize an antigen that the body has previously encountered and initiate a corresponding immune response. Generally, they are secondary, tertiary and other subsequent immune responses to the same antigen. The adaptive immune system and antigen-specific receptor generation are responsible for adaptive immune memory.

<span class="mw-page-title-main">Type 3 innate lymphoid cells</span>

Type 3 innate lymphoid cells (ILC3) are immune cells from the lymphoid lineage that are part of the innate immune system. These cells participate in innate mechanisms on mucous membranes, contributing to tissue homeostasis, host-commensal mutualism and pathogen clearance. They are part of a heterogeneous group of innate lymphoid cells, which is traditionally divided into three subsets based on their expression of master transcription factors as well as secreted effector cytokines - ILC1, ILC2 and ILC3.

Trained immunity is a long-term functional modification of cells in the innate immune system which leads to an altered response to a second unrelated challenge. For example, the BCG vaccine leads to a reduction in childhood mortality caused by unrelated infectious agents. The term "innate immune memory" is sometimes used as a synonym for the term trained immunity which was first coined by Mihai Netea in 2011. The term "trained immunity" is relatively new – immunological memory has previously been considered only as a part of adaptive immunity – and refers only to changes in innate immune memory of vertebrates. This type of immunity is thought to be largely mediated by epigenetic modifications. The changes to the innate immune response may last up to several months, in contrast to the classical immunological memory, and is usually unspecific because there is no production of specific antibodies/receptors. Trained immunity has been suggested to possess a transgenerational effect, for example the children of mothers who had also received vaccination against BCG had a lower mortality rate than children of unvaccinated mothers. The BRACE trial is currently assessing if BCG vaccination can reduce the impact of COVID-19 in healthcare workers. Other vaccines are also thought to induce immune training such as the DTPw vaccine.

Immunometabolism is a branch of biology that studies the interplay between metabolism and immunology in all organisms. In particular, immunometabolism is the study of the molecular and biochemical underpinninngs for i) the metabolic regulation of immune function, and ii) the regulation of metabolism by molecules and cells of the immune system. Further categorization includes i) systemic immunometabolism and ii) cellular immunometabolism. Immunometabolism includes metabolic inflammation:a chronic, systemic, low grade inflammation, orchestrated by metabolic deregulation caused by obesity or aging.

<span class="mw-page-title-main">Ayesha Verrall</span> New Zealand politician, physician and infectious-diseases researcher

Ayesha Jennifer Verrall is a New Zealand politician, infectious-diseases physician, and researcher with expertise in tuberculosis and international health. She is a Labour Party Member of the New Zealand Parliament and a Cabinet Minister with the roles of Minister of Health and Minister for Research, Science and Innovation. She has worked as a senior lecturer at the University of Otago, Wellington and as a member of the Capital and Coast District Health Board. During the COVID-19 pandemic she provided the Ministry of Health with an independent review and recommendations for its contact-tracing approach to COVID-19 cases.

References

  1. 1 2 "FELICITĂRI! Mihai Netea, un cercetător din Cluj, primeşte "Nobelul Olandei". Este considerat un pionier în domeniu". clujcapitala.ro (in Romanian). June 13, 2016. Retrieved April 16, 2020.
  2. 1 2 3 4 5 "Mihai Netea: A new idea in immunology". Radboud University Nijmegen. Archived from the original on April 14, 2020. Retrieved April 14, 2020.
  3. 1 2 "Prof. Mihai G. Netea MD PhD". ISCOMS. Archived from the original on January 20, 2017. Retrieved April 14, 2020.
  4. "Prof.dr. M.G. (Mihai) Netea. Publications". NARCIS. Retrieved April 14, 2020.
  5. 1 2 "Mihai Netea. Personal prizes & awards (national & international)". Radboud University Nijmegen. Archived from the original on April 14, 2020. Retrieved April 14, 2020.
  6. "NWO Spinoza prize 2016". Netherlands Organisation for Scientific Research. Archived from the original on 11 April 2020.
  7. "Mihae Netea". Academia Europaea. Archived from the original on 28 March 2019.
  8. "Mihai Netea". Royal Netherlands Academy of Arts and Sciences. Archived from the original on 18 April 2020.
  9. Netea, Mihai G. (2013). "Training innate immunity: the changing concept of immunological memory in innate host defence". European Journal of Clinical Investigation. 43 (8): 881–884. doi: 10.1111/eci.12132 . PMID   23869409. S2CID   29501882.
  10. Netea, M. G.; Joosten, L. A.; Latz, E.; Mills, K. H.; Natoli, G.; Stunnenberg, H. G.; O'Neill, L. A.; Xavier, R. J. (2016). "Trained immunity: a program of innate immune memory in health and disease". Science. 352 (6284): aaf1098. doi:10.1126/science.aaf1098. PMC   5087274 . PMID   27102489.
  11. Netea, Mihai G.; Ferwerda, Gerben; Van Der Graaf, Chantal; Van Der Meer, Jos W.; Kullberg, Bart Jan (2006). "Recognition of Fungal Pathogens by Toll-Like Receptors". Current Pharmaceutical Design. 12 (32). https://eurekaselect: 4195–4201. doi:10.2174/138161206778743538. PMID   17100622 . Retrieved September 11, 2020.
  12. Kumar, V.; Van De Veerdonk, F. L.; Netea, M. G. (2018). "Antifungal immune responses: emerging host–pathogen interactions and translational implications". Genome Medicine. 10 (1): 39. doi: 10.1186/s13073-018-0553-2 . PMC   5968547 . PMID   29801518.
  13. Netea, Mihai G.; Van De Veerdonk, Frank L.; Van Deuren, Marcel; Van Der Meer, Jos WM (2011). "Defects of pattern recognition: primary immunodeficiencies of the innate immune system". Current Opinion in Pharmacology. 11 (4). sciencedirect.com: 412–422. doi:10.1016/j.coph.2011.03.003. PMID   21498117 . Retrieved September 11, 2020.
  14. Leentjens, J.; Kox, M.; Koch, R. M.; Preijers, F.; Joosten, L. A.; Van Der Hoeven, J. G.; Netea, M. G.; Pickkers, P. (2012). "Reversal of Immunoparalysis in Humans In Vivo A Double-Blind, Placebo-controlled, Randomized Pilot Study". American Journal of Respiratory and Critical Care Medicine. 186 (9): 838–45. doi:10.1164/rccm.201204-0645OC. PMID   22822024.
  15. 1 2 "Prof. M.G. Netea (Mihai)". Radboud University. Retrieved 12 September 2020.
  16. 1 2 "Limes - Department of Immunology and Metabolism". LIMES-Institut, Universität Bonn. Retrieved 12 September 2020.
  17. 1 2 "Spinoza Prize for Mihai Netea". RIMLS. Retrieved 12 September 2020.
  18. Despre O istorie genetică (incompletă) a românilor at the Humanitas website]
  19. "Novel antagonists of the toll-like receptor 4" . Retrieved 11 September 2020.